Strategies for discontinuation of proton pump inhibitors: a systematic review
Open Access
- 5 September 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 31 (6) , 625-630
Abstract
Proton pump inhibitors (PPIs) are considered to be overprescribed. Consensus on how to attempt discontinuation is, however, lacking. We therefore conducted a systematic review of clinical studies on discontinuation of PPIs. Systematic review based on clinical studies investigating discontinuation strategies and discontinuation rates for users of antisecretory medication judged eligible for withdrawal. The databases Medline, Embase and Cochrane Library were searched to December 2013 using the terms antisecretory, anti-ulcer, PPI, acid suppressant, discontinuation, step-down, step down, cessation, tapering, withdrawal and withhold. Search terms were used either singularly or in combination. Papers written in English or Scandinavian were included. Concurrent hand searching was undertaken to pursue references of references. The website ClinicalTrials.gov was searched for unpublished results and ongoing studies. A total of 371 abstracts were scrutinized to determine relevancy. The thorough search resulted in six clinical studies on strategies for discontinuation of PPIs. All discontinuation regimens used in the studies differed, and several interventions have been tested in order to decrease use of PPIs. Discontinuations were reported across all studies ranging from 14% to 64% without deteriorating symptom control. Tapering seems to be a more effective discontinuation strategy than abrupt discontinuation. Discontinuation of PPIs is feasible in a clinical setting, and a substantial number of the patients treated without a clear indication can safely reduce or discontinue treatment. Tapering seems to be the most effective way of doing this.Keywords
This publication has 9 references indexed in Scilit:
- The risks of PPI therapyNature Reviews Gastroenterology & Hepatology, 2012
- Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapseEuropean Journal of Gastroenterology & Hepatology, 2010
- Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of TherapyGastroenterology, 2009
- Overprescribing proton pump inhibitorsBMJ, 2008
- Discontinuation of proton pump inhibitors in patients on long‐term therapy: a double‐blind, placebo‐controlled trialAlimentary Pharmacology & Therapeutics, 2006
- American Gastroenterological Association Medical Position Statement: Evaluation of DyspepsiaGastroenterology, 2005
- Patient‐directed strategy to reduce prescribing for patients with dyspepsia in general practice: a randomized trialAlimentary Pharmacology & Therapeutics, 2004
- Step-down management of gastroesophageal reflux diseaseGastroenterology, 2001
- Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resourceSocial Science & Medicine, 2000